Effect of contact lens wear on the diurnal profile of matrix metalloproteinase 9 in tears

Optometry and Vision Science

Volumn 90, Issue 5, 2013, Pages 419-429

  Markoulli, Maria ^a   Papas, Eric ^a,b   Cole, Nerida ^c   Holden, Brien ^a,b  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b VISION COOPERATIVE RESEARCH CENTRE   (Australia)

^c UNIVERSITY OF TECHNOLOGY SYDNEY   (Australia)

Author keywords

contact lens; extended wear; MMP 9; tear film

Indexed keywords

ADAPTIVE PROCESS; CONTACT LENS WEAR; EXTENDED WEARS; MATRIX METALLOPROTEINASE-9; MMP-9; NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN; TEAR FILMS; TISSUE INHIBITOR OF METALLOPROTEINASES;

OPHTHALMOLOGY; OPTOMETERS;

CONTACT LENSES;

GELATINASE B; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ADULT; ARTICLE; CIRCADIAN RHYTHM; COMPARATIVE STUDY; CONTACT LENS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENZYMOLOGY; EQUIPMENT DESIGN; FEMALE; FOLLOW UP; HUMAN; LACRIMAL FLUID; MALE; METABOLISM; MIDDLE AGED; MYOPIA; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; YOUNG ADULT;

ADOLESCENT; ADULT; CIRCADIAN RHYTHM; CONTACT LENSES; EQUIPMENT DESIGN; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; MYOPIA; PROSPECTIVE STUDIES; TEARS; TISSUE INHIBITOR OF METALLOPROTEINASE-1; YOUNG ADULT;

EID: 84876830322     PISSN: 10405488     EISSN: 15389235     Source Type: Journal    
DOI: 10.1097/OPX.0b013e31828d7d3b     Document Type: Article

References (42)

1. Sivak JM, Fini ME. MMPs in the eye: emerging roles for matrix metalloproteinases in ocular physiology. Prog Retin Eye Res 2002; 21:1-14.
2. Sternlicht MD, Werb Z. How matrix metalloproteinases regulate cell behavior. Annu Rev Cell Dev Biol 2001;17:463-516.
3. Fini ME, Girard MT. Expression of collagenolytic/gelatinolytic metalloproteinases by normal cornea. Invest Ophthalmol Vis Sci 1990;31:1779-88.
4. Sobrin L, Liu Z, Monroy DC, Solomon A, Selzer MG, Lokeshwar BL, Pflugfelder SC. Regulation of MMP-9 activity in human tear fluid and corneal epithelial culture supernatant. Invest Ophthalmol Vis Sci 2000;41:1703-9.
5. Lema I, Duran JA. Inflammatory molecules in the tears of patients with keratoconus. Ophthalmology 2005;112:654-9.
6. Afonso AA, Sobrin L, Monroy DC, Selzer M, Lokeshwar B, Pflugfelder SC. Tear fluid gelatinase B activity correlates with IL- 1alpha concentration and fluorescein clearance in ocular rosacea. Invest Ophthalmol Vis Sci 1999;40:2506-12.
7. Chotikavanich S, de Paiva CS, Li de Q, Chen JJ, Bian F, Farley WJ, Pflugfelder SC. Production and activity of matrix metalloproteinase- 9 on the ocular surface increase in dysfunctional tear syndrome. Invest Ophthalmol Vis Sci 2009;50:3203-9.
8. Pal-Ghosh S, Blanco T, TadvalkarG, Pajoohesh-Ganji A, Parthasarathy A, Zieske JD, Stepp MA. MMP9 cleavage of the beta4 integrin ectodomain leads to recurrent epithelial erosions in mice. J Cell Sci 2011;124:2666-75.
9. Stapleton F, Keay L, Edwards K, Naduvilath T, Dart JK, Brian G, Holden BA. The incidence of contact lens-related microbial keratitis in Australia. Ophthalmology 2008;115:1655-62.
10. Dumbleton K. Noninflammatory silicone hydrogel contact lens complications. Eye Contact Lens 2003;29:S186-9.
11. Willcox MD, Naduvilath TJ, Vaddavalli PK, Holden BA, Ozkan J, Zhu H. Corneal erosions, bacterial contamination of contact lenses, and microbial keratitis. Eye Contact Lens 2010;36:340-5.
12. Berry M, Pult H, Purslow C, Murphy PJ. Mucins and ocular signs in symptomatic and asymptomatic contact lens wear. Optom Vis Sci 2008;85:930-8.
13. Daniels JT, Geerling G, Alexander RA, Murphy G, Khaw PT, Saarialho-Kere U. Temporal and spatial expression of matrix metalloproteinases during wound healing of human corneal tissue. Exp Eye Res 2003;77:653-64.
14. Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem 1993;268:10425-32.
15. Markoulli M, Papas E, Cole N, Holden BA. The diurnal variation of matrix metalloproteinase-9 and its associated factors in human tears. Invest Ophthalmol Vis Sci 2012;53:1479-84.
16. Leonardi A, Brun P, Abatangelo G, PlebaniM, Secchi AG. Tear levels and activity of matrix metalloproteinase (MMP)-1 and MMP-9 in vernal keratoconjunctivitis. Invest Ophthalmol Vis Sci 2003;44: 3052-8.
17. Papas EB, Petznick A, Garrett Q, Stapleton F. Involvement of matrixmetalloproteinase-9 (MMP-9) and tissue inhibitor of matrixmetalloproteinase-1 (TIMP-1) during orthokeratology. Invest Ophthalmol Vis Sci 2006;47:E-Abstract 117.
18. Ehrmann K, Fedtke C, Radi( A. Assessment of computer generated vision charts. Cont Lens Anterior Eye 2009;32:133-40.
19. CCLRU Grading Scales. Appendix D. In: Phillips AJ, Speedwel L, eds. Contact Lenses, 4th ed. Boston, MA: Butterworth-Heinemann; 1997:864-7.
20. Markoulli M, Papas E, Petznick A, Holden B. Validation of the flush method as an alternative to basal or reflex tear collection. Curr Eye Res 2011;36:198-207.
21. Sack RA, Tan KO, Tan A. Diurnal tear cycle: evidence for a nocturnal inflammatory constitutive tear fluid. Invest Ophthalmol Vis Sci 1992;33:626-40.
22. Hawkes SP, Li H, Taniguchi GT. Zymography and reverse zymography for detecting MMPs, and TIMPs. Methods Mol Biol 2001;151:399-410.
23. Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG. Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem 1995;270:6351-6.
24. Roy R, Louis G, Loughlin KR, Wiederschain D, Kilroy SM, Lamb CC, Zurakowski D, Moses MA. Tumor-specific urinary matrix metalloproteinase fingerprinting: identification of high molecular weight urinary matrix metalloproteinase species. Clin Cancer Res 2008;14:6610-7.
25. Barro CD, Romanet JP, Fdili A, Guillot M, Morel F. Gelatinase concentration in tears of corneal-grafted patients. Curr Eye Res 1998; 17:174-82.
26. Kumagai N, Yamamoto K, Fukuda K, Nakamura Y, Fujitsu Y, Nuno Y, Nishida T. Active matrix metalloproteinases in the tear fluid of individuals with vernal keratoconjunctivitis. J Allergy Clin Immunol 2002;110:489-91.
27. Lema I, Duran JA, Ruiz C, Diez-Feijoo E, Acera A, Merayo J. Inflammatory response to contact lenses in patients with keratoconus compared with myopic subjects. Cornea 2008;27:758-63.
28. Thakur A, Willcox MD. Contact lens wear alters the production of certain inflammatory mediators in tears. Exp Eye Res 2000; 70:255-9.
29. Tan KO, Sack RA, Holden BA, Swarbrick HA. Temporal sequence of changes in tear film composition during sleep. Curr Eye Res 1993;12:1001-7.
30. Carney FP, Morris CA, Willcox MD. Effect of hydrogel lens wear on the major tear proteins during extended wear. Aust N Z J Ophthalmol 1997;25(Suppl. 1):S36-8.
31. Stapleton F, Willcox MD, Morris CA, Sweeney DF. Tear changes in contact lens wearers following overnight eye closure. Curr Eye Res 1998;17:183-8.
32. McClellan KA, Cripps AW, Clancy RL, Billson FA. The effect of successful contact lens wear on mucosal immunity of the eye. Ophthalmology 1998;105:1471-7.
33. Stapleton F, Keay L, Jalbert I, Cole N. The epidemiology of contact lens related infiltrates. Optom Vis Sci 2007;84:257-72.
34. Van den Steen PE, Dubois B, Nelissen I, Rudd PM, Dwek RA, Opdenakker G. Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol 2002;37:375-536.
35. Olson MW, Bernardo MM, Pietila M, Gervasi DC, Toth M, Kotra LP, Massova I, Mobashery S, Fridman R. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin. J Biol Chem 2000;275:2661-8.
36. Luan Y, Kong L, Howell DR, Ilalov K, Fajardo M, Bai XH, Di Cesare PE, Goldring MB, Abramson SB, Liu CJ. Inhibition of ADAMTS-7 and ADAMTS-12 degradation of cartilage oligomeric matrix protein by alpha-2-macroglobulin. Osteoarthritis Cartilage 2008;16:1413-20.
37. Shiomi T, Lemaitre V, D'Armiento J, Okada Y. Matrix metalloproteinases, a disintegrin and metalloproteinases, and a disintegrin and metalloproteinases with thrombospondin motifs in nonneoplastic diseases. Pathol Int 2010;60:477-96.
38. Sack RA, Sathe S, Beaton AR, Bogart B, Lew G. Changes in the diurnal pattern of the distribution of gelatinases and associated proteins in normal and pathological tear fluids: evidence that the PMN cell is a major source of MMP activity in tear fluid. Adv Exp Med Biol 2002;506:539-45.
39. Lu L, Reinach PS, Kao WW. Corneal epithelial wound healing. Exp Biol Med (Maywood) 2001;226:653-64.
40. Carnt N, Jalbert I, Stretton S, Naduvilath T, Papas E. Solution toxicity in soft contact lens daily wear is associated with corneal inflammation. Optom Vis Sci 2007;84:309-15.
41. Smith VA, Khan-Lim D, Anderson L, Cook SD, Dick AD. Does orally administered doxycycline reach the tear film? Br J Ophthalmol 2008;92:856-9.
42. Kim HS, Luo L, Pflugfelder SC, Li DQ. Doxycycline inhibits TGFbeta1- induced MMP-9 via Smad and MAPK pathways in human corneal epithelial cells. Invest Ophthalmol Vis Sci 2005;46:840-8.